Screening for inhibitors against SARS-CoV-2 and its variants

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, generating new variants that pose a threat to global health; therefore, it is imperative to obtain safe and broad-spectrum antivirals against SARS-CoV-2 and its variants. To this end, we screened compounds for their ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Weijing, Dong, Xiaojing, Chen, Lan, Lei, Xiaobo, Zhou, Zhuo, Guo, Li, Wang, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier BV. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077799/
https://www.ncbi.nlm.nih.gov/pubmed/35574239
http://dx.doi.org/10.1016/j.bsheal.2022.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077799/
https://www.ncbi.nlm.nih.gov/pubmed/35574239
http://dx.doi.org/10.1016/j.bsheal.2022.05.002

Ejemplares similares